Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Craigbadon Dec 23, 2016 3:16pm

196 Views

Post# 25641227

RE:Nothing else to talk about

Great article Sky. Kind of confirms my thesis. Hopefully the company will do a big enough raise to last them a couple of years and will have a nice warrant attached to help spice it up. The big question will be what kind of price per share the can raise at given most valuations are using very high multiples based on 2020 earnings which are a long ways away and certainly have a risk ridden path to get to. It would be nice to see a raise in the $1.30-1.40 area with a warrant attached and large enough to take off the financing overhang for an extended period.